Bar Harbor Wealth Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bar Harbor Wealth Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-29,735	Closed	-$3.38M	–	260
2022 Q4	$3.38M	Sell	29,735 -1,997	-6%	-$166K	0.27%	89
2022 Q3	$1.96M	Sell	31,732 -1,902	-6%	-$133K	0.17%	110
2022 Q2	$2.68M	Buy	33,634 +30,824	+1,097%	+$2.92M	0.21%	103
2022 Q1	$295K	Sell	2,810 -580	-17%	-$56.5K	0.03%	193
2021 Q4	$366K	Sell	3,390 -1,285	-27%	-$140K	0.03%	181
2021 Q3	$512K	Sell	4,675 -230	-5%	-$23.9K	0.05%	151
2021 Q2	$460K	Sell	4,905 -2,635	-35%	-$242K	0.04%	163
2021 Q1	$694K	Buy	7,540 +70	+0.9%	+$5.91K	0.07%	139
2020 Q4	$546K	Buy	7,470 +4,070	+120%	+$303K	0.05%	151
2020 Q3	$264K	Buy	+3,400	New	+$234K	0.03%	205

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bar Harbor Wealth Management's HZNP Position: Q1 2023 in Review

Bar Harbor Wealth Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 29,735 shares — an estimated $3.38M sold.

Bar Harbor Wealth Management first reported a position in HZNP in Q3 2020 and held it in 10 quarters. The position peaked at $3.38M in Q4 2022. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

Bar Harbor Wealth Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Bar Harbor Wealth Management sold 29,735 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $3.38M.
Bar Harbor Wealth Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2020 and held it in 10 quarters.
Bar Harbor Wealth Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $3.38M in Q4 2022.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Bar Harbor Wealth Management's 13F filing for Q1 2023, filed 24 Apr 2023.